Article PDF
Avoid common mistakes on your manuscript.
References
Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5–25.
Maschak CA, Lobo RA, Dozono-Takono R et al. Comparison of pharmacodynamic properties of various oestrogen formulations. Am J Obstet Gynecol 1982; 144: 511–18.
Hammond CB, Maxson WS. Estrogen replacement therapy. Clin Obstet Gynecol 1986; 29: 407–30.
Neumann F. The physiological action of progesterone and the pharmacological effects of progestogens. A short review. Postgrad Med 1978; 54: 11–24.
Bloom RA, Laws JW. Humeral cortical thickness as an index of osteoporosis in women. Br J Radiol 1970; 43: 522–7.
Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985; 6: 1–7.
Cohn SH, Aloia JF, Vaswani AN, Zanzi I, Vestsky D, Ellis KJ. Age and sex related changes in bone mass by neutron activation. In: Menczel J et al., eds. Osteoporosis. Chichester: Wiley, 1982; 33–43.
Davis ME, Lanzl LH, Cox AB. Detection, prevention and retardation of postmenopausal osteoporosis. Obstet Gynecol 1970; 36: 187–98.
Garn SM. The phenomenon of bone formation and bone loss. In: Deluca HF et al., eds. Osteoporosis, recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981; 1–16.
Garn SM, Rohmann Cg, Wagner B. Bone loss as a general phenomenon in man. Fed Proc 1967; 26: 1729–36.
Jasani C, Nordin BEC, Smith DA, Swanson I. Spinal osteoporosis and the menopause. Proc R Soc Med 1965; 58: 441–4.
Krolner B, Nielsen SP. Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clin Sci 1982; 62: 329–36.
Lindsay R. Osteoporosis and its relationship to estrogen. Contemp Obstet Gynecol 1984; 63: 201–24.
Madsen M. Vertebral and peripheral bone mineral content by photon absorptionmetry. Invest Radiol 1977; 12: 185–8.
Mazess RB. Advances in total body and regional bone mineral by dual-photon absorptiometry. In: Menczel J et al., eds. Osteoporosis. Chichester: Wiley, 1982; 80–6.
Maziere B, Kuntz D, Dughesnay M. In vivo analysis of bone calcium by local neutron activation of the hand in postmenopausal osteoporosis. In: Menczel J et al., eds. Osteoporosis. Chichester: Wiley 1982; 117–25.
Meema HE. Cortical bone atrophy and osteoporosis as a manifestation of aging. AJR 1963; 89: 1287–95.
Meema HE. Menopausal and aging changes in muscle mass and bone mineral content. J Bone Joint Surg 1966; 48A: 1138–44.
Nordin BEC, MacGregor J, Smith DA. The incidence of osteoporosis in normal women: its relation to age and the menopause. Q J Med 1966; 137: 25–38.
Solomon L. Bone density in aging Caucasian and African populations. Lancet 1979; i: 1326–30.
Albright F, Bloomberg F, Smith PH. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940; 55: 298–305.
Albright F, Reifenstein EC Jr. Metabolic bone disease: osteoporosis. In: Albright F, Reifenstein EC, eds., Parathyroid glands and metabolic bone disease. Baltimore: Williams and Wilkins, 1948; 145–204.
Arnold JS, Bartley MH, Tont SA, Jenkins DP. Skeletal changes in aging and disease. Clin Orthop Rel Res 1966; 49: 17–38.
Leichter I, Weinreb A, Hazan G et al. The effect of age and sex on bone density, bone mineral content and cortical index. Clin Orthop Rel Res 1981; 156: 232–39.
Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67: 328–35.
Trotter M, Hixon BB. Sequential changes in weight, density and percentage weight of human skeletons from an early fetal period through old age. Anat Rec 1974; 179: 1–8.
Stevenson JC, Lee B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factors for future osteoporosis? Br Med J 1989; 298: 924–28
Lindsay R, Cosman F, Herrington B, Himmelstein (in preparation.)
Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass; a study of changes about the time of the menopause. J Clin Invest 1987; 80: 1261–9.
Lindsay R, Coutts JRT, Hart DM. Endogenous oestrogen and bone loss following oophorectomy. Calcif Tissue Res 1977; 22: 213–16.
Heaney RP, Recker RR, Saville PD. Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr 1977; 30: 1603–11.
Heaney RP, Becker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978; 92: 953–63.
Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodelling. J Lab Clin Med 1978; 92: 964–70.
Fogelman I, Poser JW, Smith ML, Hart DM, Bevan JA. Alterations in skeletal metabolism following oophorectomy. In: Christiansen C et al., eds. Osteoporosis. Glostrup, Denmark: Aalborg Stiftsbogtrykkeri, 1984; 519–22.
Aitken JM, Hart DM, Anderson JB, Lindsay R, Smith DA. Osteoporosis after oophorectomy for non-malignant disease. Br Med J 1973; i: 325–8.
Parfitt AM. Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 1979; 28: 1–5.
Dempster DW, Shane E, Horbert WS, Lindsay R. A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Min Res 1986; 1: 15–21.
Jensen PB, Jensen J, Riis BJ, Rodbro P, Strom V, Christiansen C. Climacteric symptoms after oral and percutaneous hormone replacement therapy. Maturitas 1987; 9: 207–15.
Steingold KA, Laufer L, Chetkowski RJ et al. Treatment of hot flushes with transdermal estradiol administration. J Clin Endocrinol Metab 1985; 61: 627–632.
Punnonen R, Rauramo L. The effect of long-term oral oestriol succinate therapy on the skin of castrated women. Ann Chir Gynaecol 1977; 66: 214–15.
Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977; 4: 31–47.
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303: 1195–8.
Lindsay R, Hart DM, Forrest G, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–4.
Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319–24.
Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics program follow-up study. Circulation 1987; 75: 1102–9.
Ross RK, Paganini-Hill A, Mach TM. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; i: 858–60.
Nachtigall LE, Nachtigall RH, Nachtigall RD. Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979; 54: 74–79.
Morrison JC, Martin DC, Blair RA et al. The use of medroxypro-gesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol 1980; 138: 99–104.
Lindsay R, Hart DM, Purdie D, Ferguson MM, Clark AS, Kraszewski A. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci 1978; 54: 193–5.
Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 1985; 66: 789–92.
Christiansen C, Christiensen MS, McNair P, Hagen C, Stocklund K-E, Transbol I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273–9.
Christiansen C, Christensen MS, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i: 459–61.
Lindsay R, Aitken JM, Anderson JB, Hart DMM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976; i: 1038–40.
Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol I. Prevention of early postmenopausal bone loss. Controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273–9.
Recker RR, Saville PD, Heaney RP. The effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977; 87: 649–55.
Horsman A, Gallagher JC, Simpson M, Nordin BEC. Prospective trial of estrogen and calcium in postmenopausal women. Br Med J 1977; ii: 789–92.
Riis BJ, Thomsen K, Strom V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987; 156: 61–5.
Christiansen C, Riis BJ. 17 Estradiol and Cortinuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; in press.
Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987; 156: 1516–23.
Nachtigall LE, Nachtigall RH, Nachtigall RD. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979; 53: 277.
Lindsay R, Tohme J. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 1990; 76: 1–6.
Horsman A, Jones M, Francis R, Nordin BEC. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983; 309: 1405–7.
Riis BJ, Jensen J, Christiansen C. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy. Clin Endocrinol 1987; 26: 327–34.
Christensen MS, Hagen C, Christiansen C, Transbol I. Doseresponse evaluation of cyclic estrogen/gestagen in postmenopausal women. Placebo-controlled trial of its gynecologic and metabolic actions. Am J Obstet Gynecoll 1982; 144: 873–9.
Lindsay R, Hart CM, Clarke DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1983; 63: 759–63.
Gotfredsen A, Nilas L, Riis BJ, Thomsen K, Christiansen C. in early Bone changes occurring spontaneously and caused by oestrogen postmenopausal women: a local or generalized phenomenon? Br Med J 1986; 292: 1098–100.
Riis BJ, Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646–53.
Stevenson JC, Banks LM, Spinks TJ et al. Regional and total skeletal measurements in the early postmenopause. J Clin Invest 1987; 80: 258–62.
Lindsay R, Hart DM, MacLean A, Clark AC, Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978; i: 1325–7.
Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal oestrogen protects against factures of hip and distal radius. A case-control study. Lancet 1979; ii: 705–9.
Kreiger N, Kelsey JL, Holford TR, O'Connor T. An epidemiologic study of hip fractures in postmenopausal women. Am J Epidemiol 1982; 116: 141–8.
Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95: 28–31.
Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowvitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. N Engl J Med 1987; 317: 1169–74.
Nilas L, Christiansen C, Rodbro P. Calcium supplementation and postmenopausal bone loss. Br Med J 1984; 289: 1103–6.
Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss; a double-blind, controlled clinical study. N Engl J Med 1987; 316: 173–7.
Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.Ann Intern Med 1987; 106: 40.
Riis BJ, Nilas L, Christiansen C. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss? Bone Miner 1987; 2: 1.
Stevenson JC, Abeyasekera G, Hillyard CJ. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause. Eur J Clin Invest 1983; 13: 481–7.
Greenberg C, Kirkreja SC, Bowser EN, Hargis GK, Henderson WT, Williams GA. Effect of estradiol and progesterone on calcium secretion. Endocrinology 1990; 118: 2594–8.
Heaney RP. A unified concept of osteoporosis. Am J Med 1965; 39: 377–80.
Komm BS, Terpening CM, Benz DJ. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241: 81–4.
Erikssen EF, Colvard DS, Berg NJ. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christiansen, C., Lindsay, R. Estrogens, bone loss and preservation. Osteoporosis Int 1, 7–13 (1990). https://doi.org/10.1007/BF01880410
Issue Date:
DOI: https://doi.org/10.1007/BF01880410